Literature DB >> 28571231

Central Variant of Posterior Reversible Encephalopathy Syndrome - A Rare Case Report.

K G Srinivasan1, Padhmini Balasubramanian2, K R Mayilvaganan2, Usha Nandhini Kannan2, Mohamed Bilal2.   

Abstract

Posterior Reversible Encephalopathy Syndrome (PRES) is a clinicoradiological condition associated with headache, altered mental status, dizziness and white matter vasogenic oedema in parieto-occipital region. It is often associated with hypertension but can also occur in diverse clinical settings like immunosuppression, eclampsia, etc. It is due to failure of autoregulatory mechanism of posterior circulation in response to change in blood pressure. We hereby report a rare case of central variant of PRES secondary to severe hypertension diagnosed with 3T MRI. Objective of reporting this case was to describe the imaging findings of typical and rare atypical patterns of PRES. A 71-year-old male hypertensive patient was referred for brain imaging with history of short period of loss of consciousness, headache and dizziness. MRI brain showed central variant pattern of PRES with preferential involvement of brainstem, thalami and periventricular white matter with sparing of frontal, parietal and occipital lobes. The patient was treated with anti-hypertensive after which patient's symptoms subsided. The patient was followed up conservatively. Atypical variants of PRES should be borne in mind when pontine hyperintensity is encountered in hypertensive patient.

Entities:  

Keywords:  Hypertension; Magnetic resonance imaging; Pontine hyperintensity

Year:  2017        PMID: 28571231      PMCID: PMC5449877          DOI: 10.7860/JCDR/2017/23269.9682

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Clinical and radiological features of brainstem variant of hypertensive encephalopathy.

Authors:  Ioannis Karakis; James A Macdonald; Maria Stefanidou; Carlos S Kase
Journal:  J Vasc Interv Neurol       Date:  2009-04

Review 2.  Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions.

Authors:  Juan A Guzmán-De-Villoria; Concepción Ferreiro-Argüelles; Pilar Fernández-García
Journal:  Semin Ultrasound CT MR       Date:  2010-06       Impact factor: 1.875

3.  The resolution of central variant of posterior reversible encephalopathy syndrome.

Authors:  Rita Maciel; Hipólito Nzwalo; Raquel Palma; Denis Pizhin; Alexandra Martins; Motassen Shamassa
Journal:  Neurohospitalist       Date:  2015-04

4.  Teaching neuroimages: Central variant of posterior reversible encephalopathy syndrome.

Authors:  David Yen-Ting Chen; Ying-Chi Tseng; Hui-Ling Hsu; Yen-Lin Huang; Chi-Jen Chen
Journal:  Neurology       Date:  2014-05-13       Impact factor: 9.910

5.  Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings.

Authors:  Alexander M McKinney; James Short; Charles L Truwit; Zeke J McKinney; Osman S Kozak; Karen S SantaCruz; Mehmet Teksam
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

6.  Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome.

Authors:  W S Bartynski; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

7.  Central-variant posterior reversible encephalopathy syndrome: brainstem or basal ganglia involvement lacking cortical or subcortical cerebral edema.

Authors:  Alexander M McKinney; Bharathi D Jagadeesan; Charles L Truwit
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

  7 in total
  2 in total

1.  Central-Variant Posterior Reversible Encephalopathy Syndrome with Albuminocytologic Dissociation.

Authors:  Sang-Woo Lee; Seung-Jae Lee
Journal:  Case Rep Neurol       Date:  2018-02-02

2.  Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome With Atypical Regions: A Descriptive Study With a Large Sample Size.

Authors:  Kunhua Li; Yang Yang; Dajing Guo; Dong Sun; Chuanming Li
Journal:  Front Neurol       Date:  2020-03-24       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.